Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.
Caterina VizzardelliM GindlS RoosChristian MöbsB NaglF ZimmannV SexlL KennerA NeunkirchnerG J ZlabingerW F PicklW PfütznerBarbara BohlePublished in: Allergy (2017)
Our data demonstrate that post-AIT sera with IgE-blocking activity ameliorate allergic airway inflammation in a human/mouse chimeric model of respiratory allergy independently of AIT-induced cellular changes.